Sennosides and Dalfampridine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sennosides (senna) and Dalfampridine (dalfampridine). Common drug interactions include gait disturbance among females and arthritis among males.

The phase IV clinical study analyzes what interactions people have when they take Sennosides and Dalfampridine. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Sennosides?

Sennosides has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 8,247 Sennosides users. Check the latest studies of Sennosides.

What is Dalfampridine?

Dalfampridine has active ingredients of dalfampridine. eHealthMe is studying from 9,658 Dalfampridine users. Check the latest studies of Dalfampridine.

On Jul, 14, 2026

16 people who take Sennosides and Dalfampridine together, and have interactions are studied.

Sennosides and Dalfampridine drug interactions.

What are the common drug interactions of Sennosides and Dalfampridine, by gender? *:

female:

Gait disturbance
Asthenia (weakness)
Fatigue (feeling of tiredness)
Fall
Headache (pain in head)
Arthralgia (joint pain)
Arthropathy
Back pain
Breast pain
Depressed mood

male:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Arthropathy
Cellulitis (infection under the skin)
Erythema (redness of the skin)
Infusion related reaction
Muscular weakness (muscle weakness)
Sinusitis (inflammation of sinus)
Ligament sprain (ligament stretched)
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Sennosides and Dalfampridine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Arthropathy
Cellulitis (infection under the skin)
Erythema (redness of the skin)
Infusion related reaction
Muscular weakness (muscle weakness)
Sinusitis (inflammation of sinus)
Somnolence (a state of near-sleep, a strong desire for sleep)
Affective disorder (mental disorder)
Asthenia (weakness)

60+:

Gait disturbance
Arthralgia (joint pain)
Fatigue (feeling of tiredness)
Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
Headache (pain in head)
Herpes zoster
Hot flush (sudden feelings of heat)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Muscle disorder (muscle disease)
Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 50.00%
Fatigue (feeling of tiredness): 5 people, 31.25%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 25.00%
Joint Swelling: 4 people, 25.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 18.75%
Gait Disturbance: 2 people, 12.50%
Weakness: 1 person, 6.25%
Sensorimotor Disorder (disease of sensory and motor function of brain): 1 person, 6.25%
Pneumonia: 1 person, 6.25%
Pain: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Sennosides and Dalfampridine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously